Answers are grounded in this paper and cite their sources.
Chemoradiotherapy-induced decreased Hb levels have negative influence on locoregional control and survival, and might counteract the benefit of neoadjuvant/concomitant chemotherapy. Further studies on supportive care to maintain sufficient Hb level during chemo-radiotherapy are warranted.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: